BriSTAR Immunotech to Present at the BIO CEO Investor Conference
- Written by PR Newswire
BEIJING and TORONTO, Feb. 2, 2023 /PRNewswire/ -- BriSTAR Immunotech, a clinical-stage cell therapy company, announced today that its Chief Executive Officer, James Pan, Ph.D., will be presenting at the 25th BIO CEO & Investor Conference. The conference will take place at the New York Marriott Marquis during February 6-9, 2023.
Dr. Pan's...
Read more: BriSTAR Immunotech to Present at the BIO CEO Investor Conference














